Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Augmedix
(NASDAQ:AUGX)
Intraday
$2.90
0.11
[3.94%]
After-Hours
$2.90
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.90
0.11
[3.94%]
At close: Apr 26
$2.90
0
[0.00%]
After Hours: 4:04PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Augmedix Stock (NASDAQ:AUGX)
Augmedix Stock (NASDAQ: AUGX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 24, 2024
Augmedix Announced The General Availability Of Augmedix Go For Emergency Departments (EDs), Marking The Launch Of The Industry's First Fully-automated, Generative Ai Powered Medical Documentation Product For EDs Across The Country
Benzinga Newsdesk
-
3 days ago
Tuesday, April 09, 2024
Analyst Ratings For Augmedix
Benzinga Insights
-
Apr 9, 2024, 4:00PM
Evercore ISI Group Upgrades Augmedix to Outperform, Raises Price Target to $5
Benzinga Newsdesk
-
Apr 9, 2024, 3:18PM
Augmedix Integrates With Andor Health To Streamline Ambient Clinical Documentation For Ambulatory Virtual Care
Benzinga Newsdesk
-
Apr 9, 2024, 7:18AM
Thursday, April 04, 2024
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
Benzinga Newsdesk
-
Apr 4, 2024, 7:12AM
Wednesday, April 03, 2024
B. Riley Securities Reinstates Buy on Augmedix, Announces $5.5 Price Target
Benzinga Newsdesk
-
Apr 3, 2024, 2:06PM
Tuesday, March 19, 2024
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Mar 19, 2024, 1:48PM
Evercore ISI Group Maintains In-Line on Augmedix, Lowers Price Target to $4.5
Benzinga Newsdesk
-
Mar 19, 2024, 11:28AM
Maxim Group Maintains Buy on Augmedix, Lowers Price Target to $5
Benzinga Newsdesk
-
Mar 19, 2024, 10:15AM
Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 19, 2024, 8:10AM
Augmedix shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY24 revenue guidance.
Benzinga Newsdesk
-
Mar 19, 2024, 7:50AM
Monday, March 18, 2024
Augmedix Expects To Generate Approximately $60M-$62M Of Revenue In 2024. Est $61.53M
Benzinga Newsdesk
-
Mar 18, 2024, 6:15PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Mar 18, 2024, 5:33PM
Recap: Augmedix Q4 Earnings
Benzinga Insights
-
Mar 18, 2024, 4:10PM
Augmedix Q4 2023 GAAP EPS $(0.09) Beats $(0.10) Estimate, Sales $12.680M Beat $12.466M Estimate
Benzinga Newsdesk
-
Mar 18, 2024, 4:05PM
Earnings Scheduled For March 18, 2024
Benzinga Insights
-
Mar 18, 2024, 5:57AM
Friday, March 15, 2024
Earnings Outlook For Augmedix
Benzinga Insights
-
Mar 15, 2024, 11:00AM
Friday, January 05, 2024
Augmedix Exits Calendar 2023 With Expected $51M In Annual Recurring Revenue; Sees Q4 Revenue Of ~$12.5M
Benzinga Newsdesk
-
Jan 5, 2024, 8:20AM
Friday, December 15, 2023
Evercore ISI Group Initiates Coverage On Augmedix with In-Line Rating, Announces Price Target of $6
Benzinga Newsdesk
-
Dec 15, 2023, 9:12AM
Wednesday, December 13, 2023
Augmedix Partners With Google Cloud To Bring Medically-Tuned AI Technology To Ambient Documentation
Benzinga Newsdesk
-
Dec 13, 2023, 10:06AM
Thursday, November 23, 2023
Augmedix Recent Insider Activity
Benzinga Insights
-
Nov 23, 2023, 10:05AM
Thursday, November 16, 2023
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Nov 16, 2023, 1:11PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Nov 16, 2023, 12:31PM
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 16, 2023, 8:08AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Nov 16, 2023, 8:06AM
Augmedix Priced of Upsized Public Offering of 6.25M Shares, up from Prior 5.5M at $4.00/Share
Benzinga Newsdesk
-
Nov 16, 2023, 2:31AM
Wednesday, November 15, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Nov 15, 2023, 4:31PM
Augmedix Announces Proposed Public Offering Of 5.5M Shares Of Common Stock
Benzinga Newsdesk
-
Nov 15, 2023, 4:10PM
Tuesday, November 07, 2023
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Nov 7, 2023, 1:10PM
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Nov 7, 2023, 10:54AM
Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 7, 2023, 8:28AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Nov 7, 2023, 8:06AM
Monday, November 06, 2023
Augmedix Now Expects ~$44.5M Of Revenue In 2023 Vs $43.73M Est.;
Benzinga Newsdesk
-
Nov 6, 2023, 5:37PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Nov 6, 2023, 4:31PM
Augmedix Q3 EPS $(0.10) Beats $(0.12) Estimate, Sales $11.77M Beat $11.42M Estimate
Benzinga Newsdesk
-
Nov 6, 2023, 4:24PM
Earnings Scheduled For November 6, 2023
Benzinga Insights
-
Nov 6, 2023, 8:24AM
Friday, November 03, 2023
Augmedix's Earnings Outlook
Benzinga Insights
-
Nov 3, 2023, 4:01PM
Thursday, October 05, 2023
Augmedix Reaches Agreements In Principle For Strategic Collaborations With Three Digital Health Companies: Myndshft, Ellipsis Health, And The Sullivan Group
Benzinga Newsdesk
-
Oct 5, 2023, 7:15AM
Wednesday, September 27, 2023
Augmedix Announces New AI Medical Documentation Product, Augmedix Go, A Clinician-Controlled Mobile App
Benzinga Newsdesk
-
Sep 27, 2023, 7:02AM
Monday, August 07, 2023
Augmedix Sees FY23 Revenue $43.5M vs $42.6M Est.
Benzinga Newsdesk
-
Aug 7, 2023, 5:01PM
Augmedix Q2 EPS $(0.12) Beats $(0.13) Estimate, Sales $10.78M Beat $10.41M Estimate
Benzinga Newsdesk
-
Aug 7, 2023, 4:18PM
Earnings Scheduled For August 7, 2023
Benzinga Insights
-
Aug 7, 2023, 4:12AM
Friday, August 04, 2023
Augmedix's Earnings: A Preview
Benzinga Insights
-
Aug 4, 2023, 4:02PM
Friday, May 26, 2023
Augmedix Chief Strategy Officer Awarded $744K Worth of Stock Options
Benzinga Insights
-
May 26, 2023, 11:00AM
Thursday, May 18, 2023
Augmedix Board Member Acquires 10,182 Shares After Exercising Company Stock Options
Benzinga Insights
-
May 18, 2023, 11:00AM
Tuesday, May 16, 2023
Analyst Expectations for Augmedix's Future
Benzinga Insights
-
May 16, 2023, 3:01PM
Benchmark Reiterates Buy on Augmedix, Maintains $6 Price Target
Benzinga Newsdesk
-
May 16, 2023, 9:35AM
Monday, May 15, 2023
B. Riley Securities Maintains Buy on Augmedix, Raises Price Target to $5.5
Benzinga Newsdesk
-
May 15, 2023, 9:17AM
Friday, May 12, 2023
Augmedix: Q1 Earnings Insights
Benzinga Insights
-
May 12, 2023, 9:30AM
Earnings Scheduled For May 12, 2023
Benzinga Insights
-
May 12, 2023, 8:22AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch